Inventaire - your friends and communities are your best library

DHEA treatment: myth or reality?

Author

Wiebke Arlt

Bruno Allolio

1949 - 2015

Published in: Trends in Endocrinology and Metabolism

Date of publication: September 1, 2002

Bibliographic databases:

Cites articles 58

Date

Title

Authors

November 1, 1975

Hormonal changes in puberty III: Correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late ad,Hormonal Changes in Puberty III: Correlation of Plasma Dehydroepiandrosterone,Testosterone, FSH, and LH with Stages of Puberty and Bone Age in Normal Boys and Girls and in Patients with Addison's Disease or Hypogonadism or with Premature or Late Adrenarche,Hormonal changes in puberty III: Correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche
May 1, 1977

Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities
September 1, 1980

Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence
August 1981

Characterization and measurement of dehydroepiandrosterone sulfate in rat brain
September 1, 1984

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood
September 1984

Origin of plasma androstanediol glucuronide in men
April 1, 1985

Dissociation of adrenal androgen and cortisol levels in acute stress
November 1, 1989

Precursors of plasma androstanediol- and androgen-glucuronides in women
August 1, 1990

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor

,
April 1, 1990

Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells
July 1, 1991

Intracrinology
January 1, 1991

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor

,
March 1, 1992

Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues

,
May 1, 1992

The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells
January 1, 1993

Quality of life in patients with Addison's disease: effects of different cortisol replacement modes
December 1, 1993

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
August 1, 1994

Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey
January 1, 1994

Decreased psychological well-being in adult patients with growth hormone deficiency
December 1, 1995

Replacement of DHEA in aging men and women. Potential remedial effects
December 1, 1995

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial
February 1, 1996

Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors
November 1, 1996

Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study

,
October 1, 1998

A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly

, , ,
July 1, 1998

The actions of exogenous dehydroepiandrosterone in experimental animals and humans,The Actions of Exogenous Dehydroepiandrosterone in Experimental Animals and Humans
June 1, 1998

Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression
April 1, 1998

Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development,Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development
August 1, 1998

A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy
October 1, 1998

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
July 1, 1998

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
June 1, 1998

Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence
February 1, 1998

Activation of human monocytes by LPS and DHEA,Activation of Human Monocytes by LPS and DHEA
June 1, 1999

Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens

Article -

Welcome to inventaire

The library of your friends and communities

Learn more